What is the 52 Week High and Low of Ind-Swift Laboratories Share Price?

The 52 week high and low prices of Ind-Swift Laboratories share price is 173.25 & 79.8. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Ind-Swift Laboratories Share price

Q: How to buy Ind-Swift Laboratories Share at Choice?

To buy Ind-Swift Laboratories stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Ind-Swift Laboratories, choose your preferred order type, and place the trade.

INDSWFTLAB

Healthcare Small Cap

158

1.31 (0.84%)

NSE

BSE

Last updated on 5 Jun, 2026 | 15:43 IST

BuySell

Today's High

163.50

Today's Low

156.20

52 Week Low

79.80

52 Week High

173.25

Ind-Swift Laboratories Chart

ChartIQ

TradingView

Ind-Swift Laboratories Share Key Metrics

Volume

12.76 L

Market Cap

1370.04 CR

LTQ@LTP

339@158.00

ATP

159.66 Var Margin

25.62 %

Circuit Range

125.36-188.02

Delivery %

0 %

Value

20.37 CR

ASM/GSM

No

Market Lot

1

Summary

Ind-Swift Laboratories share price is ₹158 as of 5 Jun, 2026. The stock Ind-Swift Laboratories intraday movement has stayed between ₹156.20 and ₹163.50, while on a 52-week basis,Ind-Swift Laboratories price 52 week high is ₹173.25 & its 52 week low is ₹79.80.

In terms of trading activity, Ind-Swift Laboratories has recorded a volume of 1275663 shares, The Ind-Swift Laboratories has a market cap of ₹86711558 CR. The stock’s Average Traded Price (ATP) stands at ₹159.66, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 339 @ ₹158.00.

Ind-Swift Laboratories operates within a circuit range of ₹125.36 – ₹188.02, with a Value of ₹20.37 CR. The Delivery Percentage for the day is 0%. Additionally, Ind-Swift Laboratories currently falls under the No framework, and trades with a market lot size of 1.

Ind-Swift Laboratories Fundamentals

P/E Ratio

32.85

P/B Ratio

0.92

Div. Yield

0

Sector P/E

69.13

Sector P/B

2.98

Sec. Div. Yield

0.54

Ind-Swift Laboratories Resistance and Support

Pivot 156.41

Resistance

First Resistance

160.02

Second Resistance

163.35

Third Resistance

166.96

Support

First Support

153.08

Second Support

149.47

Third Support

146.14

Ind-Swift Laboratories Shareholding Pattern

2016-17
2018-19
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27
2019-20
2017-18

Total Promoters

Segment

Percent

Total Promoters

42%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0.46%

Domestic Institutional Investors

0.94%

Retail

56.6%

Others

0%

Total Promoters

MAR '24

42%

JUN '24

42.01%

SEP '24

42%

DEC '24

42%

Ind-Swift Laboratories Corporate Actions

Date	Agenda
2026-05-28	Audited Results
2026-01-31	Quarterly Results
2025-11-14	Quarterly Results
2025-05-30	Audited Results
2025-02-13	Quarterly Results
2025-02-12	Quarterly Results

Ind-Swift Laboratories News

Ind-Swift Laboratories Ltd - 532305 - Statement Of NIL Deviation For The Quarter Ended March 31, 2026

Ind Swift Laboratories informed that Rs.58.99 crore from a preferential issue of convertible warrants is now non-receivable. This is due to an allottee failing to convert their warrants within the stipulated timeframe, which impacts the total realizable funds.

May 28 2026 20:30:44

Ind-Swift Laboratories Ltd - 532305 - Board Meeting Outcome for Audited Financial Results For The Quarter And Financial Year Ended 31St March 2026

Ind Swift Laboratories reported its FY26 results, with consolidated net profit plummeting 83.5% to ₹41.42 cr despite an 11.6% rise in consolidated revenue to ₹641.29 cr. The results cover the combined entity post-amalgamation with Ind Swift Limited.

May 28 2026 20:01:31

Ind-Swift Laboratories Ltd - 532305 - Board Meeting Intimation for Meeting To Be Held On May 28, 2026.

Ind Swift Laboratories board is scheduled to meet on May 28, 2026. The meeting's agenda includes considering and approving the standalone and consolidated audited financial results for Q4 FY26.

May 22 2026 17:21:40

Name	Position
Pardeep Verma	VP-Corp. Affairs, Company Secretary & Compliance Officer
Navrattan Munjal	Chairman & Managing Director

Ind-Swift Laboratories Similar Stocks

Beta Drugs Ltd.

1466.70

-5.00 (0.34%)

Amrutanjan Health Care Ltd.

552.05

9.30 (1.71%)

Suraksha Diagnostic Ltd.

275.20

-3.80 (1.36%)

Jagsonpal Pharmaceuticals Ltd.

203.04

-0.41 (0.20%)

Syncom Formulations (India) Ltd.

14.49

-0.08 (0.55%)

Laxmi Dental Ltd.

229.90

1.06 (0.46%)

GPT Healthcare Ltd.

149.64

-2.79 (1.83%)

Ind-Swift Laboratories FAQs

The Buying Price of Ind-Swift Laboratories share is 158 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Ind-Swift Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Ind-Swift Laboratories, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Ind-Swift Laboratories shares is 32.85. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Ind-Swift Laboratories shares is 0.92. Useful to assess the stock's value relative to its book value.

To assess Ind-Swift Laboratories’s valuation compare Sector P/E, P/B which are 69.13 & 2.98 with sector averages, along with growth rates and financial metrics.

The Market Cap of Ind-Swift Laboratories is 1370.04 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Ind-Swift Laboratories share price is 173.25 & 79.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Ind-Swift Laboratories belongs to the Healthcare sector.